Quality of Life in Primary Insomnia: Three-week Treatment With Zolpidem Vs. Lorazepam

1. Lloyd GG (1995). Psychiatry. In Edwards CRW, Bouchier IAD, Haslett C, Chilvers ER, eds. Davidson’s Principles and Practice of Medicine, 978-1019. 17th ed. Edinburgh: Churchil Livingstone.Search in Google Scholar

2. Lustbader AS, Morgan C, Pelayo R, Vasquez LS, Yuen K (1997). Insomnia. In Rucker LM, ed. Essentials of adult ambulatory care 607-17. Baltimore: Williams and Wilkins.Search in Google Scholar

3. Ohayon MM: Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997; 31: 333-46.10.1016/S0022-3956(97)00002-2Open DOISearch in Google Scholar

4. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE: Cognitive behavioral therapy for treatment of chronic primary insomnia. A randomized controlled trial. JAMA 2001; 285: 1856-64.10.1001/jama.285.14.1856Search in Google Scholar

5. Lee-Chiong T (2008). Sleep Medicine- Essentials and Review, pp 73-133. Oxford University press.Search in Google Scholar

6. Buysse JD: Chronic Insomnia. Am J Psychiatry 2008; 165(6): 678-686.10.1176/appi.ajp.2008.08010129Search in Google Scholar

7. Pigeon RW: Diagnosis, prevalence, pathways, consequences & treatment of insomnia. Indian J Med Res 2010; 131: 321-332.Search in Google Scholar

8. Đukić Dejanović SM, Milovanović D, Ravanić D. et al.(2003). Nesanice- zdravstveni i ekonomski problem savremenog društva. Medicinski fakultet Kragujevac.Search in Google Scholar

9. Roth T & Ancoli-Israel S: Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation survey. II. Sleep 1999; 22: 354-8.Search in Google Scholar

10. Simon GE & VonKorff M:Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997; 154: 1417-23.10.1176/ajp.154.10.1417Search in Google Scholar

11. Balter MB: Uhlenhuth EH. New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry 1992; 53 (suppl 12): 34-9.Search in Google Scholar

12. Longmore M, Wilkinson I, Torok E (2001). Oxford handbook of clinical medicine. 5th ed. Oxford: Oxford University Press.Search in Google Scholar

13. Kyle SD, Morgan K, Espie CA: Insomnia and health-related quality of life. Sleep Medicine Reviews 2010; 14: 69-82.10.1016/j.smrv.2009.07.004Open DOISearch in Google Scholar

14. Hauri PJ: Can we mix behavioral therapy with hypnotics when treating insomniacs? Sleep 1997; 20: 1111-8.10.1093/sleep/20.12.1111Search in Google Scholar

15. Ashton H: The treatment of benzodiazepine dependence. Addiction. 1994; 89(11): 1535-41.10.1111/j.1360-0443.1994.tb03755.xSearch in Google Scholar

16. Seltzer JK, Kurt TL, Knodel LC, Dean B, Burch C: Texas Medicaid Vendor Drug Program Drug Utilization Review Board. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. J Am Pharm Assoc 2000; 40: 495-9.10.1016/S1086-5802(15)30395-8Search in Google Scholar

17. Buysse DJ, Reynolds CF, Kupfer DJ, Thorpy MJ, Bixler E, Manfredi R et al.: Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994; 17: 630-7.10.1093/sleep/17.7.630Search in Google Scholar

18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000.Search in Google Scholar

19. Soldatos CR, Dikeos DG, Paparrigopoulos TJ: Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000; 48: 555-60.10.1016/S0022-3999(00)00095-7Search in Google Scholar

20. Bliwise DL, Seidel WF, Cohen SA, Bliwise NG, Dement WC: Profile of mood states changes during and after 5 weeks of nightly triazolam administration. J Clin Psychiatry 1988; 49(9): 349-55.Search in Google Scholar

21. Zisapel N & Nir T: Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale. J Sleep Res 2003; 12: 291-298.10.1046/j.0962-1105.2003.00365.x14633240Open DOISearch in Google Scholar

22. Morin CM, Stone J, Trinkle D, Mercer J, Remsberg S: Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging. 1993; 8(3): 463-7.10.1037/0882-7974.8.3.463Open DOISearch in Google Scholar

23. Whitehead S & Ali S: Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010; 96: 5-21.10.1093/bmb/ldq03321037243Search in Google Scholar

24. Slobogean GP, O’Brien PJ, Brauer CA: Single-dose versus multiple-dose antibiotic prophylaxis for the surgical treatment of closed fractures. Acta Orthop 2010; 81(2): 256-62.10.3109/17453671003587119289534820148647Open DOISearch in Google Scholar

25. Sakai M, Shimbo T, Omata K, Takahashi Y, SatomuraK, Kitamura T et al.: Cost-effectiveness of gargling for the prevention of upper respiratory tract infections. BMC Health Serv Res 2008; 8: 258.10.1186/1472-6963-8-258265187419087312Search in Google Scholar

26. Yen ZS, Davis MA, Chen SC, Chen WJ: A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women. Acad Emerg Med 2003; 10(4): 309-14.Search in Google Scholar

27. Sajid MS, Tonsi A, Baig MK: Health-related quality of life measurement. Int J Health Care Qual Assur. 2008; 21(4): 365-73.10.1108/0952686081088016218785462Search in Google Scholar

28. Mihajlović G, Jovanović-Mihajlović N, Radmanović B, Radonjić K, Djukić-Dejanović S, Janković S et al.: Quality of life of schizophrenic patients treated with haloperidol depot and injection preparation of long-lasting risperidone. Srp Arh Celok Lek. 2011; 139 (1): 36-40.10.2298/SARH11S1036MSearch in Google Scholar

29. Testa MA & Simonson DC: Assesment of quality-of-life outcomes. N Engl J Med 1996; 334(13): 835-40. 10.1056/NEJM1996032833413068596551Search in Google Scholar

30. Kelly F, Delahaye C, Gal M: Quality of life in insomnia - results of validation studies for a specifically designed questionnaire. JAMA 1993; 3:21-6.Search in Google Scholar

31. Goldenberg F, Hindmarch I, Joyce CRB, Legal M, Partinen M, Pilate C: Zopiclone, sleep and health-related quality-of-life. Human Psychopharmacology- Clinical and Experimental 1994; 9: 245-51.10.1002/hup.470090403Open DOISearch in Google Scholar

32. Manuel DG, Schultz SE, Kopec JA: GroupMeasuringthe Health Burden of Chronic Disease and Injury Using Health Adjusted Life Expectancy and the Health Utilities Index. Journal of Epidemiology and Community Health 2002; 56(11): 843-850.10.1136/jech.56.11.843173204412388577Search in Google Scholar

33. Moksin Mićić A (2005). Kvalitet života u rubnim zonoma grodova u Evropskoj uniji i Srbiji. In Održivi razvoj i njegovo okruženje 19-33. Beograd: Institut za arhitekturu i urbanizom Srbije.Search in Google Scholar

34. Arsovski S: Put od kvaliteta do kvaliteta života. Zbornik radova Festival kvaliteta 2005; 32. nacionalna konferencija o kvalitetu, Kragujevac, 2005; 1: 3-16.Search in Google Scholar

35. Radojlović J & Petrović NM:Stres svuda oko nas - prevladavanje hroničnog stresa. Zdravstvena zaštita 2011; 40(2): 79-82.Search in Google Scholar

36. Roberts H: Serbia and Montenegro’s state services behind rest of Europe. Lancet 2003; 361(9354): 316-7.10.1016/S0140-6736(03)12367-7Search in Google Scholar

37. Garfield R: Economic sanctions on Yugoslavia. Lancet 2001; 358(9281): 580.10.1016/S0140-6736(01)05713-0Search in Google Scholar

38. Torrance GW, Feeny D, Furlong W: Visual Analog Scales: Do They Have a Role in the Measurement of Preferences for Health States? Med Decis Making 2001; 21: 329-334.10.1177/02729890122062622Open DOISearch in Google Scholar

39. Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, et al.: Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000; 23: 1087-96.10.1093/sleep/23.8.1hOpen DOISearch in Google Scholar

40. Hajak G, Cluydts R, Declerck A, Estivill SE, Middleton A, Sonka K, et al.: Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a largescale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol 2002; 17: 9-17.10.1097/00004850-200201000-0000211800507Search in Google Scholar

41. Martin SA, Aikens JE, Chervin RD: Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev 2004; 8: 63-72.10.1016/j.smrv.2003.08.00115062211Search in Google Scholar

42. Leger D, Scheuermaier K, Philip P, Paillard M, GuilleminaultC: SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med. 2001; 63:49-55.10.1097/00006842-200101000-0000611211064Open DOISearch in Google Scholar

43. Reynolds CF, Buysse DJ, Kupfer DJ (1995). Disordered sleep: developmental and biopsychosocial perspectives on the diagnosis and treatment of persistent insomnia. In Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress 1617-29. New York: Raven Press.Search in Google Scholar

44. Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T; ZOLONG Study Group: Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008; 31(1): 79-90.10.1093/sleep/31.1.79222555218220081Search in Google Scholar

45. Morin CM, Vallieres A, Guay B, Ivers H, Savard J, Merette C et al.: Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009; 301(19): 2005-1510.1001/jama.2009.682305062419454639Search in Google Scholar